# The Effect of Nicotinamide Riboside on Skeletal Muscle Function in Heart Failure Subjects

> **NCT03565328** · PHASE2 · TERMINATED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 2 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DIETARY_SUPPLEMENT:** Nicotinamide Riboside

## Key facts

- **NCT ID:** NCT03565328
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-09-27
- **Primary completion:** 2019-11-18
- **Final completion:** 2019-11-18
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Slow/insufficient accrual and investigators have left the study.
- **Last updated:** 2020-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03565328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03565328, "The Effect of Nicotinamide Riboside on Skeletal Muscle Function in Heart Failure Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03565328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*